在慢性阻塞性肺病 (TRIPOLI) 中,使用额外的单个吸入器与多个设备的吸入三重疗法:经授权后的回顾性研究
Eva Cabrera César1, Javier López García1, Daniel Enrique Vega Lizarazo1
1Pulmonology Department, Virgen de la Victoria University Hospital, Málaga, Spain.
概括
与多次吸入器三重疗法 (MITT) 相比,切换为慢性阻塞性肺病 (COPD) 的超细单吸入器三重疗法 (efSITT) 显著减少了恶化,并改善了坚持治疗. 这项现实世界的研究强调了efSITT的作用.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 三重治疗对于不受控制的慢性阻塞性肺病 (COPD) 是至关重要的,但通常涉及多个吸入器,可能会影响患者的坚持.
- 现实世界证据比较超细单吸入器三重疗法 (efSITT) 与多吸入器三重疗法 (MITT) 对于中度至重度的COPD是有限的.
研究的目的:
- 为了比较efSITT与MITT在中度至重度COPD患者中的有效性.
- 为了评估对恶化的影响,在现实环境中使用救援药物,坚持和肺功能.
主要方法:
- 特里波利研究是一项单中心的回顾性观察性研究.
- 在71名COPD患者中,它比较了一年的efSITT (贝克洛梅他二酸盐,福莫特醇烟酸二,糖) 与一年的MITT.
主要成果:
- efSITT显著减少了总恶化的27.56%和中度恶化的29.56%.
- 通过efSITT,患者的坚持显著改善,不良坚持从30.2%降低到9.9%,完全坚持从55.8%增加到81.7%.
- 使用efSITT的平均强迫呼气体积在第一秒内 (% pred) 提高了2.29%;没有观察到肺炎发病率的差异.
结论:
- 从MITT切换到efSITT可以减少中度至重度COPD患者的恶化.
- 在现实世界的设置中改善的坚持是可能导致efSITT.com观察到的好处的一个因素.
相关概念视频
01:23Inhaled Medications
415
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
415
01:26COPD: Management Using Bronchodilators and Corticosteroids
331
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
331
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.0K